Jorge Fernández Fradejas (Jorge Fernández-Fradejas)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Advanced Cancer

Acute Respiratory Distress Syndrome

Clostridium Difficile

Community Dwelling

Top Venues

Journal of clinical medicine

European journal of hospital pharmacy : science and practice

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge Fernández Fradejas, Eva Delgado-Silveira, María Pilar Gómez-Serranillos, Ana María Álvarez-Díaz, Manuel Vélez-Díaz-Pallarés
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV. HIV medicine 25 (5) (2024)
Jorge Fernández Fradejas, Eva Delgado-Silveira, María Pilar Gómez-Serranillos, Ana María Álvarez-Díaz, Manuel Vélez-Díaz-Pallarés
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV. HIV medicine 25 (5) (2024)
Jorge Fernández Fradejas, Hilario Martínez-Barros, Lourdes Rexach-Cano, Ana María Álvarez-Díaz, Eva Delgado-Silveira
Deprescribing in older patients with advanced cancer referred to palliative care. BMJ supportive & palliative care (2024)
Jorge Fernández Fradejas, Eva Delgado-Silveira, María Pilar Gómez-Serranillos, Ana María Álvarez-Díaz, Manuel Vélez-Díaz-Pallarés
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV. HIV medicine (2024)
Lucía Quesada Muñoz, Jorge Fernández Fradejas, Hilario Martínez-Barros, Marina Sánchez Cuervo, Miriam Martín Rufo, Maria Del Rosario Pintor Recuenco, Carmen Quereda Rodríguez-Navarro, Ana María Álvarez-Díaz, Javier Saez de la Fuente
Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir. European journal of hospital pharmacy : science and practice (2023)
Maria Ruiz-Ruigomez, Alfonso Muriel García, Sergio García Fernández, Angela Valencia Alijo, Mariona Tasias Pitarch, Esperanza Merino De Lucas, Angela Gutierrez Rojas, Antonio Ramos Martínez, Miguel Salavert Lletí, Livia Giner, María Ruíz Ruigomez, Lorena García Basas, Jorge Fernández Fradejas, María Olmedo Sampedrio, Angela Cano Yuste, Beatriz Díaz Pollán, María Jesús Rodríguez Hernández, Oriol Martín Segarra, Carmen Sáez Bejar, Carlos Armiñanzas Castillo, Belén Gutiérrez Gutiérrez, Dolors Rodríguez-Pardo, Julián De La Torre Cisneros, Francisco López Medrano, Javier Cobo Reinoso
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study. The Journal of antimicrobial chemotherapy 77 (7) (2022)
Rosa Escudero-Sanchez, Maria Ruiz-Ruigomez, Jorge Fernández Fradejas, Sergio García-Fernández, María Olmedo Samperio, Angela Cano Yuste, Angela Valencia Alijo, Beatriz Díaz Pollán, María Jesús Rodríguez Hernández, Esperanza Merino De Lucas, Oriol Martín Segarra, Carmen Sáez Bejar, Carlos Armiñanzas Castillo, Belén Gutiérrez Gutiérrez, Dolors Rodríguez-Pardo, Antonio Ramos Martínez, Julián De La Torre Cisneros, Francisco López-Medrano, Javier Cobo Reinoso
Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection. Journal of clinical medicine 10 (1) (2020)